Literature DB >> 3073381

An implantable pump for intrarenal infusion of immunosuppressants in a canine autotransplant model.

S A Gruber1, R J Cipolle, D M Canafax, G R Erdmann, B A Burke, J T Rabatin, P E Hynes, J A Ritz, F H Gould, N L Ascher.   

Abstract

We developed a canine renal allograft model utilizing implantable infusion pumps and biocompatible catheters to investigate the pharmacokinetics of local immunosuppressive drug administration. Seven mongrel dogs underwent bilateral nephrectomy and autotransplantation of one kidney to the iliac vessels. The proximal end of an infusion catheter directed into the iliac artery was tunneled to a subcutaneously placed programmable pump. A second, sampling catheter was placed with its tip in the iliac vein. Simultaneous regional (iliac vein) and systemic (jugular vein) venous concentrations of 6-mercaptopurine (6-MP), the immunosuppressive metabolite of azathioprine, were determined during a continuous 24-h intraarterial infusion (10 mg/kg/24 hr). The gradient between regional and systemic 6-MP concentrations was maximal initially when the pump was turned on, continuously decreased until steady state was reached, and disappeared immediately after the pump was turned off. The mean ratio of steady-state iliac vein to systemic 6-MP concentrations was 5.0 +/- 1.4, demonstrating a pharmacokinetic advantage of continuous intraarterial 6-MP infusion to the autotransplanted kidney. The novel canine renal allograft model described herein overcomes the technical limitations of earlier models and represents a foundational step in the design of intrarenal infusion patterns of immunosuppressive agents which we expect to prolong survival of the allotransplanted kidney with minimal systemic drug exposure and side effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3073381     DOI: 10.1023/a:1015940802451

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  CONTINUOUS CHROMOMETRIC INFUSION OF IMMUNOSUPPRESSIVE DRUGS INTO THE ARTERIAL BLOOD SUPPLY OF A TRANSPLANTED KIDNEY.

Authors:  T MIURA; S SHAH; A M KHAZEI
Journal:  Lahey Clin Found Bull       Date:  1964 Jan-Mar

2.  Radiation reversal of acute rejection in patients with life-threatening infections.

Authors:  J P Fidler; J W Alexander; E J Smith; H C Miller; V Muthiah
Journal:  Arch Surg       Date:  1973-08

3.  Initial treatment of renal allografts with large intrarenal doses of immunosuppressive drugs.

Authors:  S L Kountz; R Cohn
Journal:  Lancet       Date:  1969-02-15       Impact factor: 79.321

4.  Regional infusion chemotherapy for prolongation of kidney allografts.

Authors:  J J Terz; R Crampton; D Miller; W Lawrence
Journal:  J Surg Res       Date:  1969-01       Impact factor: 2.192

5.  Failure of regional immunosuppressive therapy to modify renal allograft rejection.

Authors:  J C Dougherty; S L Nehlsen; R Minick; F J Veith
Journal:  Transplantation       Date:  1968-07       Impact factor: 4.939

6.  The effect of direct infusions of cortisone into the renal artery of a transplanted kidney.

Authors:  J R Ackermann; C N Barnard
Journal:  S Afr Med J       Date:  1966-01-29

7.  Local treatment of renal allografts, a promising way to reduce the dosage of immunosuppressive drugs. Comparison of various ways of administering prednisolone.

Authors:  T J Ruers; W A Buurman; J F Smits; C J van der Linden; J J van Dongen; H A Struyker-Boudier; G Kootstra
Journal:  Transplantation       Date:  1986-02       Impact factor: 4.939

8.  Constant intrarenal infusion of PGE1 into a canine renal transplant using a totally implantable pump.

Authors:  D Campbell; R Wiggins; S Kunkel; J Juni; M Tuscan; B Shapiro; J Niederhuber
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

9.  Maturation of cytotoxic T cells within sponge matrix allografts.

Authors:  N L Ascher; S Chen; R A Hoffman; R L Simmons
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  The use of local allograft irradiation following renal transplantation.

Authors:  E C Halperin; F L Delmonico; P W Nelson; W U Shipley; A B Cosimi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-07       Impact factor: 7.038

View more
  2 in total

1.  Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.

Authors:  S A Gruber; S Venkataram; D M Canafax; R J Cipolle; L Bowers; D Elsberry; M McGuiggan; P E Hynes; J A Ritz; F H Gould
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

Review 2.  Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential.

Authors:  Jonas T Schnider; Matthias Weinstock; Jan A Plock; Mario G Solari; Raman Venkataramanan; Xin Xiao Zheng; Vijay S Gorantla
Journal:  Clin Dev Immunol       Date:  2013-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.